Literature DB >> 15161041

Overexpression of Id-1 in gastric adenocarcinoma: implication for a novel diagnostic marker.

Qi Wang1, S W Tsao, Songbin Fu, Weicheng Xue, Xiangning Meng, Huichen Feng, Y C Wong, Xianghong Wang.   

Abstract

Gastric cancer is the second most common cause of cancer-related death worldwide and the highest incidence of this cancer has been reported in Asia, especially in China. Identification of early stage lesions is vital in achieving high survival rate. However, due to the lack of reliable biomarkers, the majority of gastric cancer is presented at an advanced stage. Recently, it has been reported that Id-1, a helix-loop-helix protein, may be a valuable diagnostic marker in many types of human cancer. In this study, we evaluated Id-1 protein expression in gastric cancer specimens and compared it with non-malignant tissues. In addition, to investigate whether Id-1 expression levels were associated with the aggressiveness of this disease as implicated in other cancer types, we also assessed Id-1 expression levels in primary tumours and their lymph node metastasized lesions. Our results indicate that up-regulation of Id-1 is a frequent event in gastric cancer but its expression levels are not associated with tumour metastasis. Our evidence provides a possible novel marker for the diagnosis of gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15161041

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  TGF-β1-induced expression of Id-1 is associated with tumor progression in gastric cancer.

Authors:  Huiying Ma; Ye Wei; Yongmei Leng; Shichao Li; Lingling Gao; Heng Hu; Long Chen; Fei Wang; Honglei Xiao; Chouwen Zhu; Chunmin Liang
Journal:  Med Oncol       Date:  2014-05-27       Impact factor: 3.064

2.  Inhibitor of DNA-binding-1/inhibitor of differentiation-1 (ID-1) is implicated in various aspects of gastric cancer cell biology.

Authors:  Wei Li; Chun-Hua Zhang; Yi-Lin Hong; Jun Li; Yong-Mei Hu; Cui-Fen Zhao
Journal:  Mol Biol Rep       Date:  2011-06-19       Impact factor: 2.316

3.  Structure of a dominant-negative helix-loop-helix transcriptional regulator suggests mechanisms of autoinhibition.

Authors:  Ryohei Ishii; Kazunobu Isogaya; Azusa Seto; Daizo Koinuma; Yuji Watanabe; Fumio Arisaka; So-ichi Yaguchi; Hiroaki Ikushima; Naoshi Dohmae; Kohei Miyazono; Keiji Miyazawa; Ryuichiro Ishitani; Osamu Nureki
Journal:  EMBO J       Date:  2012-03-27       Impact factor: 11.598

4.  Id1 promotes tumor cell migration in nonsmall cell lung cancers.

Authors:  Raka Bhattacharya; Jeanne Kowalski; Allison R Larson; Malcolm Brock; Rhoda M Alani
Journal:  J Oncol       Date:  2010-04-18       Impact factor: 4.375

5.  Inhibition of Id proteins by a peptide aptamer induces cell-cycle arrest and apoptosis in ovarian cancer cells.

Authors:  D S Mern; J Hasskarl; B Burwinkel
Journal:  Br J Cancer       Date:  2010-09-14       Impact factor: 7.640

6.  Ectopic expression of C/EBPalpha and ID1 is sufficient to restore defective neutrophil development in low-risk myelodysplasia.

Authors:  Christian R Geest; Miranda Buitenhuis; Edo Vellenga; Paul J Coffer
Journal:  Haematologica       Date:  2009-08       Impact factor: 9.941

7.  Downregulation of Id1 by small interfering RNA in gastric cancer inhibits cell growth via the Akt pathway.

Authors:  Guang Yang; Yan Zhang; Jianjun Xiong; Jing Wu; Changfu Yang; Hongbing Huang; Zhenyu Zhu
Journal:  Mol Med Rep       Date:  2012-01-12       Impact factor: 2.952

Review 8.  The Id-protein family in developmental and cancer-associated pathways.

Authors:  Cornelia Roschger; Chiara Cabrele
Journal:  Cell Commun Signal       Date:  2017-01-25       Impact factor: 5.712

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.